Insider Selling: 111 (NASDAQ:YI) Director Sells 49,920 Shares of Stock

111, Inc. Sponsored ADR (NASDAQ:YI) Director Yang Luke Chen sold 49,920 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $0.23, for a total value of $11,481.60. Following the completion of the sale, the director directly owned 539,462 shares of the company’s stock, valued at $124,076.26. The trade was a 8.47% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Yang Luke Chen also recently made the following trade(s):

• On Monday, June 15th, Yang Luke Chen sold 44,000 shares of 111 stock. The stock was sold at an average price of $0.23, for a total value of $10,120.00.
• On Wednesday, May 27th, Yang Luke Chen sold 3,400 shares of 111 stock. The stock was sold at an average price of $0.25, for a total value of $850.00.
• On Tuesday, May 26th, Yang Luke Chen sold 1,440 shares of 111 stock. The stock was sold at an average price of $0.27, for a total value of $388.80.

111 Trading Down 6.5%

YI opened at $4.57 on Tuesday. The stock has a fifty day simple moving average of $5.88 and a two-hundred day simple moving average of $5.66. The company has a market cap of $40.17 million, a price-to-earnings ratio of -3.26 and a beta of 0.60. 111, Inc. Sponsored ADR has a 12-month low of $2.48 and a 12-month high of $11.17.

Analyst Ratings Changes

Separately, Weiss Ratings downgraded 111 from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 4th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, 111 has an average rating of “Sell”.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.